Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient

Oral Diseases

Volumn 3, Issue SUPPL. 1, 1997, Pages

  White, T C ^a   Pfaller, M A ^b   Rinaldi, M G ^c   Smith, J ^c   Redding, S W ^c  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antifungal; Azole; Candida albicans; Drug resistance

Indexed keywords

FLUCONAZOLE; PYRROLE DERIVATIVE;

CANDIDA ALBICANS; CASE REPORT; CONFERENCE PAPER; DOSE RESPONSE; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THRUSH; TREATMENT FAILURE;

EID: 0030914272     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1997.tb00336.x     Document Type: Conference Paper

References (55)

1. Ausubel FM, Brent R, Kingston RE et al (1995). Current Protocols in Molecular Biology. John Wiley & Sons, Inc.
2. Baily GG, Perry FM, Denning DW et al (1994). Fluconazole-resistant candidosis in an HIV cohort. AIDS 8. 787-792.
3. Ben-Yaacov R, Knoller S, Caldwell G et al (1994). Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 38: 648-652.
4. Brawner DL, Cutler JE (1989). Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol 27: 1335-1341
5. Cameron ML, Schell WA, Bruch S et al (1993). Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother 37: 2449-2453.
6. Coleman DC, Bennett DE, Gallagher PJ et al (1995). Oral Candidiasis and HIV Infection: Antifungal Drug Resistance and Changes in Candida Population Dynamics. In: Greenspan JS, Greenspan D, eds. Oral Manifestations of HIV Infection. Quintessence: Chicago, IL, pp 112-118.
7. Columbo AL, Barchiese F, McGough DA et al (1995). Comparison of E-test and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J Clin Microbiol 33: 535-540.
8. Cutler JE (1991). Putative virulence factors of Candida albicans. Annu Rev Microbiol 45: 187-218.
9. Daniels TE (1995). Oral Candidiasis and HIV Infection. In Greenspan JS, Greenspan D, eds. Oral Manifestations of HIV Infection. Quintessence: Chicago, IL, pp 80-84.
10. Evans TG, Mayer J, Cohen S et al (1991). Fluconazole failure in the treatment of invasive mycoses. J Infect Dis 164: 1232-1235.
11. Galgiani J, Bartlett M, Espinel-Ingroff M et al (1992). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Proposed Standard, Volume 12, National Committee for Clinical Laboratory Standards.
12. Greenspan D, Greenspan J, Schiodt M et al (1990). AIDS and the mouth. Munksgaard: Copenhagen.
13. Heinic GS, Stevens DA, Greenspan D et al (1993). Fluconazole-resistant Candida in AIDS patients. Report of two cases. Oral Surg Oral Med Oral Pathol 76: 711-715.
14. Hellstein J, Vawter-Hugart H, Fotos P et al (1993). Genetic similarity and phenotypic diversity of commensal and pathogenic strains of Candida albicans isolated from the oral cavity. J Clin Microbiol 21: 3190-3199.
15. Hitchcock CA (1993). Resistance of Candida albicans to azole antifungal agents. Biochem Soc Trans 21: 1039-1047.
16. Hitchcock CA, Pye GW, Troke PF et al (1993). Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 37: 1962-1965.
17. Joseph HT, Hollomon D, Loeffler RS et al (1995). Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob Agents Chemother 39: 1526-1529.
18. Kwon-Chung KJ and Bennett JE (1992). Medical Mycology. Lea & Febiger: Philadelphia.
19. Law D, Moore CB, Wardle HM et al (1994). High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 34: 659-668.
20. Lockhart SR, Fritch JJ, Meier AS et al (1995). Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J Clin Microbiol 33: 1501-1509.
21. Lucatorto FM, Franker C, Hardy WD et al (1991). Treatment of refractory oral candidiasis with fluconazole. A case report. Oral Surg Oral Med Oral Pathol 71: 42-44.
22. Maniatis T, Fritsch EF, Sambrook J (1982). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
23. Marker MD, Saier MH Jr (1993). A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci 18: 13-20.
24. Michaelis S, Berkower C (1996). Sequence Comparison of Yeast ATP Binding Cassette (ABC) Proteins. Cold Spring Harb Symp Quant Biol 60: 291-309.
25. Miyasaki SH, Hicks JB, Greenspan D et al (1992). The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. J Acquir Immune Defic Syndr 5: 1039-1046.
26. Odds FC (1988). Candida and Candidosis: a Review and Bibliography. Bailliere Tindall: London.
27. Odds FC (1993). Resistance of yeast to azole-derivative antifungals. J Antimicrob Chemother 31: 463-471.
28. Parkinson T, Falconer DJ, Hitchcock CA (1995). Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob Agents Chemother 39: 1696-1699.
29. Pfaller MA, Rhine CJ, Redding SW et al (1994a). Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 32: 59-64.
30. Pfaller MA, Grant C, Morthland V et al (1994b). Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J Clin Microbiol 32: 506-509.
31. Powderly WG (1994). Resistant candidiasis. Aids Res Hum Retroviruses 10: 925-929.
32. Prasad R, De WP, Goffeau A et al (1995). Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27: 320-329.
33. Pujol C, Reynes J, Renaud F et al (1993). The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients. Proc Natl Acad Sci USA 90: 9456-9459.
34. Redding S, Smith J, Farinacci G et al (1994). Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 18: 240-242.
35. Reef SE, Mayer KH (1995). Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 1: S99-S102.
36. Reents S, Goodwin SD, Singh V (1993). Antifungal prophylaxis in immunocompromised hosts. Ann Pharmacother 27: 53-60.
37. Rex JH, Rinaldi MG, Pfaller MA (1995). Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39: 1-8.
38. Sadhu C, McEachern MJ, Rustchenko-Bulgac EP et al (1991). Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification. J Bacterial 173: 842-50.
39. Samaranayake LP, Holmstrup P (1989). Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 18: 554-564.
40. Sambrook J, Fritsch EF, Maniatis T (1989). Molecular Cloning: A Laboratory Manual. 2nd Edition. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
41. Sandven P, Bjorneklett A, Maeland A (1993). Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrob Agents Chemother 37: 2443-2448.
42. Sanglard D, Kuchler K, Ischer F et al (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39: 2378-2386.
43. Schmid J, Tay YP, Wan L et al (1995). Evidence for nosocomial transmission of Candida albicans obtained by Ca3 fingerprinting. J Clin Microbiol 33: 1223-1230.
44. Schroppel K, Rotman M, Galask R et al (1994). Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J Clin Microbiol 32: 2646-2654.
45. Sewell DL, Pfaller MA, Barry AL (1994). Comparison of broth macrodilution, broth microdilution and E-test antifungal susceptibility tests for fluconazole. J Clin Microbiol 32: 2099-2102.
46. Smith D, Boag F, Midgley J et al (1991). Fluconazole resistant Candida in AIDS [Letter: comment]. J Infect 23: 345-346.
47. Soll DR, Galask R, Schmid J et al (1991). Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol 29: 1702-1710.
48. Stevens DA, Greene SI, Lang OS (1991). Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med 151: 2458-2464.
49. Stevens DA, Odds FC, Scherer S (1990). Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis 12: 258-266.
50. Vanden Bossche H, Marichal P, Odds FC et al (1992). Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 36: 2602-2610.
51. Vanden Bossche H, Willemsens G, Marichal P (1987). Anti-Candida drugs - the biochemical basis for their activity. Crit Rev Microbiol 15: 57-72.
52. Venkateswarlu K, Denning DW, Manning NJ et al (1995). Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microbiol Lett 131: 337-341.
53. Wanger A, Mills K, Nelson PW et al (1995). Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother 39: 2520-2522.
54. Warren NG, Shadomy HJ (1991). Yeasts of medical importance. In: Balows A, Hausler WJ Jr, Herrmann KL et al, eds. Manual of Clinical Microbiology. American Society of Microbiology: Washington, DC, pp 617-629.
55. Whelan WL, Soll DR (1982). Mitotic recombination in Candida albicans: recessive lethal alleles linked to a gene required for methionine biosynthesis. Mol Gen Genet 187: 477-485.